This invention is concerned with the compound 5-(p-nitrophenyl)-2-furaldehyde 2-(2-hydroxyethyl)hydrazone. This compound possesses pharmacologic activity. It is particularly useful as an anti-inflammatory agent as evidenced by its ability to inhibit edema induced in rats by the administration of
2. Field of the Invention
This invention is directed to novel 2-trialkylsilyl 4-substituted furan compounds which serve as intermediates for the synthesis of biologically active substituted 2-furanone compounds which are active as anti-inflammatory agents. The present invention is also directed to